Pediatric Research Equity Act of 2003

Pub. L. 108–155

US Codex doesn’t hold the enacted text of this law — the public-law corpus runs from the 113th Congress (2013) onward. What it changed in the U.S. Code, reconstructed from the credit notes, is listed below.

6 sections of the Code credited to this law, found between Public Law 107-377 and Public Law 108-198.

• 21 U.S.C. § 355 — New drugs
• 21 U.S.C. § 355a — Pediatric studies of drugs
• 21 U.S.C. § 355b — Adverse-event reporting
• 21 U.S.C. § 355c — Research into pediatric uses for drugs and biological products
• 42 U.S.C. § 262 — Regulation of biological products
• 42 U.S.C. § 284m — Program for pediatric studies of drugs